Smoking Products Suppress Type I IFN During SARS-Cov-2 Infection
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), which can lead to the development severe pneumonia. While some hospital data shows a positive correlation between smoking and severe pneumonia, more molecular-level mechanisms need to be determined. The previous study investigates the mechanism of the negative effect of smoking on anti-viral infection on Type I interferons (IFNs). Research has shown that Type I IFNs play an important role in defending against SARS-Cov-2. Here, we want to investigate smoking components’ effects on SARS-CoV-2 at the molecular level in vitro and give some ideas on the correlation between smoking and syndrome..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:292, p 03095 |
|---|---|
| Enthalten in: |
E3S Web of Conferences - 292, p 03095(2021) |
| Sprache: |
Englisch ; Französisch |
|---|
| Beteiligte Personen: |
Lu Zhenni [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1051/e3sconf/202129203095 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ002672529 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ002672529 | ||
| 003 | DE-627 | ||
| 005 | 20230309171515.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1051/e3sconf/202129203095 |2 doi | |
| 035 | |a (DE-627)DOAJ002672529 | ||
| 035 | |a (DE-599)DOAJf08761a07f0747fa87d8877b701c79ef | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a fre | ||
| 050 | 0 | |a GE1-350 | |
| 100 | 0 | |a Lu Zhenni |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Smoking Products Suppress Type I IFN During SARS-Cov-2 Infection |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) is a global pandemic caused by the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), which can lead to the development severe pneumonia. While some hospital data shows a positive correlation between smoking and severe pneumonia, more molecular-level mechanisms need to be determined. The previous study investigates the mechanism of the negative effect of smoking on anti-viral infection on Type I interferons (IFNs). Research has shown that Type I IFNs play an important role in defending against SARS-Cov-2. Here, we want to investigate smoking components’ effects on SARS-CoV-2 at the molecular level in vitro and give some ideas on the correlation between smoking and syndrome. | ||
| 653 | 0 | |a Environmental sciences | |
| 773 | 0 | 8 | |i In |t E3S Web of Conferences |d EDP Sciences, 2013 |g 292, p 03095(2021) |w (DE-627)DOAJ000094145 |x 22671242 |7 nnns |
| 773 | 1 | 8 | |g volume:292, p 03095 |g year:2021 |
| 856 | 4 | 0 | |u https://doi.org/10.1051/e3sconf/202129203095 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/f08761a07f0747fa87d8877b701c79ef |z kostenfrei |
| 856 | 4 | 0 | |u https://www.e3s-conferences.org/articles/e3sconf/pdf/2021/68/e3sconf_netid21_03095.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2267-1242 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 292, p 03095 |j 2021 | ||